Kopec Anna K, Joshi Nikita, Cline-Fedewa Holly, Wojcicki Anna V, Ray Jessica L, Sullivan Bradley P, Froehlich John E, Johnson Brendan F, Flick Matthew J, Luyendyk James P
Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.
J Hepatol. 2017 Apr;66(4):787-797. doi: 10.1016/j.jhep.2016.12.004. Epub 2016 Dec 10.
BACKGROUND & AIMS: Acetaminophen (APAP)-induced liver injury is coupled with activation of the blood coagulation cascade and fibrin(ogen) accumulation within APAP-injured livers of experimental mice. We sought to define the role of fibrin(ogen) deposition in APAP-induced liver injury and repair.
Wild-type, fibrinogen-deficient mice, mutant mice with fibrin(ogen) incapable of binding leukocyte αβ integrin (Fibγ mice) and matrix metalloproteinase 12 (Mmp12)-deficient mice were fasted, injected with 300mg/kg APAP i.p. and evaluated at a range of time-points. Plasma and liver tissue were analyzed. Rescue of Fibγ mice was carried out with exogenous Mmp12. To examine the effect of the allosteric leukocyte integrin αβ activator leukadherin-1 (LA-1), APAP-treated mice were injected with LA-1.
In wild-type mice, APAP overdose increased intrahepatic levels of high molecular weight cross-linked fibrin(ogen). Anticoagulation reduced early APAP hepatotoxicity (6h), but increased hepatic injury at 24h, implying a protective role for coagulation at the onset of repair. Complete fibrin(ogen) deficiency delayed liver repair after APAP overdose, evidenced by a reduction of proliferating hepatocytes (24h) and unresolved hepatocellular necrosis (48 and 72h). Fibγ mice had decreased hepatocyte proliferation and increased multiple indices of liver injury, suggesting a mechanism related to fibrin(ogen)-leukocyte interaction. Induction of Mmp12, was dramatically reduced in APAP-treated Fibγ mice. Mice lacking Mmp12 displayed exacerbated APAP-induced liver injury, resembling Fibγ mice. In contrast, administration of LA-1 enhanced hepatic Mmp12 mRNA and reduced necrosis in APAP-treated mice. Further, administration of recombinant Mmp12 protein to APAP-treated Fibγ mice restored hepatocyte proliferation.
These studies highlight a novel pathway of liver repair after APAP overdose, mediated by fibrin(ogen)-αβ integrin engagement, and demonstrate a protective role of Mmp12 expression after APAP overdose.
Acetaminophen overdose leads to activation of coagulation cascade and deposition of high molecular weight cross-linked fibrin(ogen) species in the liver. Fibrin(ogen) is required for stimulating liver repair after acetaminophen overdose. The mechanism whereby fibrin(ogen) drives liver repair after acetaminophen overdose requires engagement of leukocyte αβ integrin and subsequent induction of matrix metalloproteinase 12.
对乙酰氨基酚(APAP)诱导的肝损伤与凝血级联反应的激活以及实验小鼠APAP损伤肝脏内纤维蛋白(原)的积累有关。我们试图确定纤维蛋白(原)沉积在APAP诱导的肝损伤和修复中的作用。
将野生型、纤维蛋白原缺陷型小鼠、纤维蛋白(原)无法结合白细胞αβ整合素的突变小鼠(Fibγ小鼠)和基质金属蛋白酶12(Mmp12)缺陷型小鼠禁食,腹腔注射300mg/kg APAP,并在一系列时间点进行评估。分析血浆和肝组织。用外源性Mmp12对Fibγ小鼠进行挽救。为了研究变构白细胞整合素αβ激活剂白细胞黏附素-1(LA-1)的作用,给APAP处理的小鼠注射LA-1。
在野生型小鼠中,APAP过量增加了肝内高分子量交联纤维蛋白(原)的水平。抗凝可降低早期APAP肝毒性(6小时),但会增加24小时时的肝损伤,这意味着凝血在修复开始时起保护作用。完全缺乏纤维蛋白(原)会延迟APAP过量后的肝脏修复,这表现为增殖肝细胞数量减少(24小时)以及肝细胞坏死未得到解决(48小时和72小时)。Fibγ小鼠的肝细胞增殖减少,多项肝损伤指标增加,提示存在一种与纤维蛋白(原)-白细胞相互作用相关的机制。在APAP处理的Fibγ小鼠中,Mmp12的诱导显著降低。缺乏Mmp12的小鼠表现出APAP诱导的肝损伤加剧,类似于Fibγ小鼠。相反,给予LA-1可增强APAP处理小鼠肝脏中的Mmp12 mRNA表达并减少坏死。此外,给APAP处理的Fibγ小鼠注射重组Mmp12蛋白可恢复肝细胞增殖。
这些研究突出了APAP过量后肝脏修复的一条新途径,该途径由纤维蛋白(原)-αβ整合素相互作用介导,并证明了APAP过量后Mmp12表达的保护作用。
对乙酰氨基酚过量会导致凝血级联反应激活以及肝脏中高分子量交联纤维蛋白(原)物种的沉积。纤维蛋白(原)是对乙酰氨基酚过量后刺激肝脏修复所必需的。纤维蛋白(原)在对乙酰氨基酚过量后驱动肝脏修复的机制需要白细胞αβ整合素的参与以及随后基质金属蛋白酶12的诱导。